
aRCC: 1L Treatment Options and Patient Management
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
ASCO GU 2022 Update on CheckMate 214 With Extended 5-Year Follow-Up: Efficacy and Safety of Nivo+Ipi vs. Sunitinib for 1L Treatment of Advanced sRCC
By
ASCO Genitourinary Cancers Symposium
FEATURING
Scott Tykodi
By
ASCO Genitourinary Cancers Symposium
FEATURING
Scott Tykodi
186 views
March 14, 2022
Comments 0
Login to view comments.
Click here to Login